封面
市場調查報告書
商品編碼
1178033

心血管診斷·監測設備的全球市場:各產品 - 產業分析,規模,佔有率,成長,趨勢,預測(2022年~2031年)

Cardiovascular Diagnostic & Monitoring Devices Market (Product: ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, and Mobile Cardiac Telemetry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日期: | 出版商: Transparency Market Research | 英文 153 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球心血管診斷·監測設備市場調查,提供市場概要,市場規模和預測,趨勢,促進因素·阻礙因素,各產品·各終端用戶·各地區的分析,及競爭情形等資訊。

目錄

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理:全球心血管診斷·監測設備市場

第4章 市場概要

  • 簡介
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球心血管診斷·監測設備市場分析·預測(2017年~2031年)
  • 波特的五力分析

第5章 主要洞察

  • 病的得病率和發生率
  • 主要產品/品牌分析
  • 心血管照護的智慧穿戴式設備:目前情形和今後的發展
  • 價值鏈分析
  • COVID-19疫情對產業的影響(價值鏈和短期·中期·長期性影響)

第6章 全球心血管診斷·監測設備市場分析·預測:各產品

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額預測,各產品(2017年~2031年)
    • ECG設備
    • 心電圖監測
    • 心臟事件記錄器
    • 置入式迴路錄音機
    • 行動心電遙測
  • 市場魅力分析,各產品

第7章 全球心血管診斷·監測設備市場分析·預測:各終端用戶

  • 簡介和定義
  • 主要調查結果/發展
  • 市場金額預測,各終端用戶(2017年~2031年)
    • 醫院
    • 診療所
    • 門診病人手術中心
    • 其他
  • 市場魅力分析,各終端用戶

第8章 全球心血管診斷·監測設備市場分析·預測:各地區

  • 主要調查結果
  • 市場金額預測,各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力分析,各地區

第9章 北美的心血管診斷·監測設備市場分析·預測

第10章 歐洲的心血管診斷·監測設備市場分析·預測

第11章 亞太地區的心血管診斷·監測設備市場分析·預測

第12章 南美的心血管診斷·監測設備市場分析·預測

第13章 中東·非洲的心血管診斷·監測設備市場分析·預測

第14章 競爭情形

  • 市場企業 - 競爭矩陣(各等級·各企業規模)
  • 市場佔有率分析,各企業,2021年
  • 有競爭力的商務策略
  • 企業簡介
    • Abbott Laboratories
    • Biotronik
    • Boston Scientific Corporation
    • GE Healthcare
    • Medtronic
    • Nihon Kohden Corporation
Product Code: TMRGL2385

TMR's report on the global cardiovascular diagnostic & monitoring devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global cardiovascular diagnostic & monitoring devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cardiovascular diagnostic & monitoring devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cardiovascular diagnostic & monitoring devices market.

The report delves into the competitive landscape of the global cardiovascular diagnostic & monitoring devices market. Key players operating in the global cardiovascular diagnostic & monitoring devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global cardiovascular diagnostic & monitoring devices market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cardiovascular Diagnostic & Monitoring Devices Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, 2017-2031
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Disease Prevalence & Incidence Rate
  • 5.2. Key Product/Brand Analysis
  • 5.3. Smart wearable devices in cardiovascular care: where we are and how to move forward
  • 5.4. Value Chain Analysis
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. ECG Devices
      • 6.3.1.1. Resting ECG Devices
      • 6.3.1.2. Stress ECG Devices
    • 6.3.2. Holter Monitors
    • 6.3.3. Event Monitors
    • 6.3.4. Implantable Loop Recorders
    • 6.3.5. Mobile Cardiac Telemetry
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Ambulatory Surgery Centers
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product, 2017-2031
    • 9.2.1. ECG Devices
      • 9.2.1.1. Resting ECG Devices
      • 9.2.1.2. Stress ECG Devices
    • 9.2.2. Holter Monitors
    • 9.2.3. Event Monitors
    • 9.2.4. Implantable Loop Recorders
    • 9.2.5. Mobile Cardiac Telemetry
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Clinics
    • 9.3.3. Ambulatory Surgery Centers
    • 9.3.4. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. ECG Devices
      • 10.2.1.1. Resting ECG Devices
      • 10.2.1.2. Stress ECG Devices
    • 10.2.2. Holter Monitors
    • 10.2.3. Event Monitors
    • 10.2.4. Implantable Loop Recorders
    • 10.2.5. Mobile Cardiac Telemetry
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Clinics
    • 10.3.3. Ambulatory Surgery Centers
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. ECG Devices
      • 11.2.1.1. Resting ECG Devices
      • 11.2.1.2. Stress ECG Devices
    • 11.2.2. Holter Monitors
    • 11.2.3. Event Monitors
    • 11.2.4. Implantable Loop Recorders
    • 11.2.5. Mobile Cardiac Telemetry
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Clinics
    • 11.3.3. Ambulatory Surgery Centers
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. ECG Devices
      • 12.2.1.1. Resting ECG Devices
      • 12.2.1.2. Stress ECG Devices
    • 12.2.2. Holter Monitors
    • 12.2.3. Event Monitors
    • 12.2.4. Implantable Loop Recorders
    • 12.2.5. Mobile Cardiac Telemetry
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Clinics
    • 12.3.3. Ambulatory Surgery Centers
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. ECG Devices
      • 13.2.1.1. Resting ECG Devices
      • 13.2.1.2. Stress ECG Devices
    • 13.2.2. Holter Monitors
    • 13.2.3. Event Monitors
    • 13.2.4. Implantable Loop Recorders
    • 13.2.5. Mobile Cardiac Telemetry
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Clinics
    • 13.3.3. Ambulatory Surgery Centers
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company, 2021
  • 14.3. Competitive Business Strategies
  • 14.4. Company Profiles
    • 14.4.1. Abbott Laboratories
      • 14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.1.2. Company Financials
      • 14.4.1.3. Growth Strategies
      • 14.4.1.4. SWOT Analysis
    • 14.4.2. Biotronik
      • 14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.2.2. Company Financials
      • 14.4.2.3. Growth Strategies
      • 14.4.2.4. SWOT Analysis
    • 14.4.3. Boston Scientific Corporation
      • 14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.3.2. Company Financials
      • 14.4.3.3. Growth Strategies
      • 14.4.3.4. SWOT Analysis
    • 14.4.4. GE Healthcare
      • 14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.4.2. Company Financials
      • 14.4.4.3. Growth Strategies
      • 14.4.4.4. SWOT Analysis
    • 14.4.5. Medtronic
      • 14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.5.2. Company Financials
      • 14.4.5.3. Growth Strategies
      • 14.4.5.4. SWOT Analysis
    • 14.4.6. Nihon Kohden Corporation
      • 14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.4.6.2. Company Financials
      • 14.4.6.3. Growth Strategies
      • 14.4.6.4. SWOT Analysis

List of Tables

  • Table 01: Global Stroke Incident Cases
  • Table 02: Global Prevalence of Heart Failure (2017)
  • Table 03: Status of Cardiac Surgeries in Countries in South Asia 2016-2017
  • Table 04: Status of Cardiac Surgeries in North America
  • Table 05: New Zealand all cardiac surgery patients in 2016: age and gender
  • Table 06: Europe Hospital discharge rates for in-patients with diseases of the cardiovascular system, 2016-2017
  • Table 07: Key Product/Brand Analysis of Implantable Loop Recorder
  • Table 08: Key Product/Brand Analysis of Holter Monitors
  • Table 09: Key Product/Brand Analysis of ECG
  • Table 10: Key Product/Brand Analysis of Event Monitors
  • Table 11: Key Product/Brand Analysis of Event Monitors
  • Table 12: Key Product/Brand Analysis of Mobile Cardiac Telemetry
  • Table 13: Ambulatory Cardiac Monitoring Devices Procedures performed till 2018
  • Table 14: Ambulatory Cardiac Monitoring Devices Procedures performed after January 2019
  • Table 15: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 16: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 17: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 19: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 20: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 21: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 22: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 23: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 24: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 25: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 26: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 27: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 28: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 29: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 30: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 33: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 34: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 35: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 36: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 37: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by ECG Devices, 2017-2031
  • Table 38: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 39: GE Healthcare Business Overview
  • Table 40: Koninklijke Philips N.V. Business Overview
  • Table 41: Medtronic plc Business Overview
  • Table 42: Abbott Laboratories Business Overview
  • Table 43: Boston Scientific Corporation Business Overview
  • Table 44: Hill-Rom Holdings, Inc. Business Overview
  • Table 45: Nihon Kohden Corporation Business Overview
  • Table 46: Asahi Kasei Medical Co., Ltd. Business Overview

List of Figures

  • Figure 01: Global Cardiovascular Diagnostic & Monitoring Devices Market Share, by Type
  • Figure 02: Global Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 03: Procedures performed in 2017 (New Zealand)
  • Figure 04: Procedures performed in 2017 (Australia)
  • Figure 05: Value Chain Analysis
  • Figure 06: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 07: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 08: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 09: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 10: Global Cardiovascular Diagnostic & Monitoring Devices Market Analysis, by Region
  • Figure 11: Global Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 12: Global Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 13: North America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country, 2020 and 2031
  • Figure 15: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country, 2021-2031
  • Figure 16: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 17: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 18: North America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 19: North America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 20: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 21: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 22: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 23: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 24: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 25: Europe Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 26: Europe Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 27: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 28: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 29: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 30: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 31: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 32: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 33: Asia Pacific Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 34: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 35: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 36: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 37: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 38: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 39: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 40: Latin America Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 41: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Country/Sub-region, 2020 and 2031
  • Figure 43: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Country/Sub-region, 2021-2031
  • Figure 44: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 45: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 46: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 47: Middle East & Africa Cardiovascular Diagnostic & Monitoring Devices Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 48: GE Healthcare Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 49: GE Healthcare Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 50: GE Healthcare Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 51: GE Healthcare R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 52: Koninklijke Philips N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 53: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 54: Koninklijke Philips N.V. Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 55: Koninklijke Philips N.V. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 56: Medtronic plc Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 57: Medtronic plc Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 58: Medtronic plc Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 59: Medtronic plc R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 60: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 61: Abbott Laboratories Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 62: Abbott Laboratories Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 63: Abbott Laboratories R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 64: Boston Scientific Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 65: Boston Scientific Corporation Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 66: Boston Scientific Corporation Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 67: Boston Scientific Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 68: Hill-Rom Holdings, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 69: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 70: Hill-Rom Holdings, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 71: Hill-Rom Holdings, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 72: Nihon Kohden Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 73: Nihon Kohden Corporation Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 74: Nihon Kohden Corporation Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 75: Nihon Kohden Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 76: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 77: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Region/Country, 2019
  • Figure 78: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (%), by Business Segment, 2019
  • Figure 79: Asahi Kasei Medical Co., Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2019